-
Start Preamble
AGENCY:
National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS).
ACTION:
Notice of issuance of final guidance publication.
SUMMARY:
The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), announces the availability of the following publication: NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2016 [2016-161].
ADDRESSES:
This document may be obtained at the following link: http://www.cdc.gov/niosh/docs/2016-161/.
Start Further InfoFOR FURTHER INFORMATION CONTACT:
Barbara A. MacKenzie, NIOSH Division of Applied Research and Technology, 1090 Tusculum Avenue, MS C-26, Cincinnati, OH 45226. 513-533-8132 (not a toll free number), bmackenzie@cdc.gov.
Start SignatureEnd Signature End Further Info End PreambleDated: September 27, 2016.
Frank Hearl,
Chief of Staff, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention.
[FR Doc. 2016-23719 Filed 9-30-16; 8:45 am]
BILLING CODE 4163-19-P
Document Information
- Published:
- 10/03/2016
- Department:
- Centers for Disease Control and Prevention
- Entry Type:
- Notice
- Action:
- Notice of issuance of final guidance publication.
- Document Number:
- 2016-23719
- Pages:
- 68019-68019 (1 pages)
- Docket Numbers:
- CDC-2015-0034, Docket Number NIOSH 233-A
- PDF File:
- 2016-23719.pdf
- Supporting Documents:
- » NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016
- » NIOSH Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings
- » NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2014
- » Proposed Additions to the NIOSH 2016 Hazardous Drugs List